Ludovic started his career studying pharmacology focusing on drug delivery systems using peptide targeting and nanotechnology approach as a postdoctoral researcher at University College London and University College Cork. He then held various positions in preclinical CROs working on oncology research program management and the development of imaging platforms. He has also worked in a hospital setting, where he developed a translational preclinical oncology platform for PDX and humanized mice in collaboration with clinicians. Ludovic’s move to industry began leading the preclinical and clinical evaluation of immuno-oncology programs, developing cancer vaccines using antibodies, from preclinical to phase I/IIa in CLL and solid tumor cancers. Ludovic’s team was responsible for conducting POC and non-clinical evaluation for the different programs as well as managing the preparation and presentation of non-clinical pharmacology sections of external documents (e.g. Investigator’s Brochure, IND/CTA, CTD).
As a pharmacologist with over 15 years of experience in the CRO/biotech industry and expertise in preclinical development of oncology drugs and vaccines, Ludovic is passionate about helping customers accelerate their early-stage drug development.